LFCR Q3 2020 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q3 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$153M-1.8% YoY

Gross Profit

$20M13.1% margin

Operating Income

-$15M-9.8% margin

Net Income

-$12M-7.5% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+7.2%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$4M

Stock-Based Comp.

$566,000

Balance Sheet

Total Assets

$550M

Total Liabilities

$302M

Stockholders' Equity

$248M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$153M	$156M	-1.8%
Gross Profit	$20M	$21M	-5.5%
Operating Income	-$15M	$3M	-670.1%
Net Income	-$12M	$1M	-1179.5%